Improving Access to Opioid Use Disorder Treatment Among Marginalized Patients With a Tailored Telehealth Intervention
Key facts
- Who runs it
- University of Pennsylvania
- Where
- Philadelphia, United StatesSee the site
- Trial code
- Status
- Not yet recruiting
- People taking part
- 60 people, planned
- Starts
- 15 Jan 2027
- Expected to end
- Apr 2028
- Type of study
- Interventional
- Treatments tested
- Telehealth for opioid use disorder treatment delivery
- Record updated
- 12 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 25 criteriaShow less
Who can take part
- For patients:
- Must be 18 years old or older
- Clinical diagnosis of opioid use disorder and/or mental health diagnosis
- Must be receiving treatment for opioid use disorder and/or mental health diagnosis at an outpatient community-based substance use disorder and/or mental health treatment program
- Must speak English
- For providers and staff:
- Must be 18 years old or older
- Must be in a provider, clinical staff, or leadership role caring for patients with substance use disorders and/or mental health diagnoses
- Must speak English
- Aim 2b:
- Must be 18 years or older
- Clinical diagnosis of opioid use disorder
- Must be receiving treatment for OUD with buprenorphine at Prevention Point Philadelphia
- Must speak English
- Aim 3:
- Patient participants:
- Must be 18 years old or older
- Clinical diagnosis of opioid use disorder
- Must be currently receiving in-person disorder care with buprenorphine at Prevention Point for a duration of 1-3 months OR not currently receiving disorder treatment but approved for treatment intake at buprenorphine clinic by Prevention Point clinician
- Must be English speaking
- Provider and staff participants:
- Must be a provider or staff member at Prevention Point Philadelphia in the buprenorphine OUD treatment program
- Must be involved in the care of at least one patient enrolled in the pilot trial
- Must be English speaking
Other criteria
- Aim 1:
Where in United States
- University of PennsylvaniaPhiladelphia, United StatesContact: Shoshana Aronowitz, PhDNot yet recruiting
About the trial
What the trial wants to find out
The goal of this pilot trial is to develop and test a telehealth intervention for OUD care delivery and refine measurement strategies.
Read full original descriptionShow less
The specific aims are to: 1) identify components of an effective telehealth intervention and barriers to implementation, 2) partner with an advisory board of OUD treatment stakeholders from different settings to develop a telehealth intervention for OUD treatment with buprenorphine, and 3) conduct a pilot trial of the telehealth intervention for OUD treatment.
The investigators will enroll 60 patients, 30 individuals who are currently enrolled in in-person OUD treatment with buprenorphine, with a treatment episode duration of 1-3 months, and 30 individuals who are not currently receiving OUD treatment but approved for treatment intake at buprenorphine clinic by an OUD treatment clinician, to receive the telehealth for OUD care delivery intervention. The investigators will measure clinical, implementation, and patient satisfaction outcomes.
The group in the trial
- Patients with OUD, eligible for treatment with buprenorphineTreatment being tested
Treatment: Telehealth for opioid use disorder treatment delivery
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 12 November 2026